1. Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer
   Iwona Sidorkiewicz et al, 2023, Scientific Reports CrossRef
2. Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis
   Kristen A. Engevik et al, 2023, PLOS ONE CrossRef
3. N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
   Jinhui Liu et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
4. CircRNA-miRNA-mRNA interactome analysis in endometrial cancer
   Tikam Chand Dakal et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
5. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma
   Jinhui Liu et al, 2021, Frontiers in Immunology CrossRef
6. Prognostic Biomarker-Based Identification of Drugs for Managing the Treatment of Endometrial Cancer
   Dilraj Kaur et al, 2021, Molecular Diagnosis & Therapy CrossRef
7. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis
   Shijin Huang et al, 2021, Frontiers in Genetics CrossRef